ID   BT092
AC   CVCL_UK57
DR   Wikidata; Q93432815
RX   PubMed=30153289;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
RX   PubMed=30153289; DOI=10.1371/journal.pone.0202860;
RA   Yuan A.L., Ricks C.B., Bohm A.K., Lun X.-Q., Maxwell L., Safdar S.,
RA   Bukhari S., Gerber A., Sayeed W., Bering E.A., Pedersen H.,
RA   Chan J.A.W., Shen Y.-Q., Marra M.A., Kaplan D.R., Mason W., Goodman L.D.,
RA   Ezhilarasan R., Kaufmann A.B., Cabral M., Robbins S.M., Senger D.L.,
RA   Cahill D.P., Sulman E.P., Cairncross J.G., Blough M.D.;
RT   "ABT-888 restores sensitivity in temozolomide resistant glioma cells
RT   and xenografts.";
RL   PLoS ONE 13:E0202860-E0202860(2018).
//